Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gunvor Ahlborg, MD, PHD., et al. – Endothelin (ET)-1 is a vasoconstrictor and proinflammatory peptide that may inhibit glucose uptake. The objective of the study was to investigate if ET (selective ETA and dual ETA+ETB) receptor blockade improves insulin sensitivity in patients with insulin resistance and coronary artery disease...Conclusion: Dual ETA+ETB receptor blockade acutely enhances insulin sensitivity in patients with insulin resistance and coronary artery disease, indicating an important role for endogenous ET-1

Today in Clinical Pharmacology...keeping you current

Successful treatment of non-healing wounds with Xelma
British Journal of Nursing, 12/16/09

The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying
Journal of Gastroenterology, 12/16/09

Pilot study: the use of sulfasalazine for the treatment of acute pouchitis
Alimentary Pharmacology and Therapeutics, 12/16/09

Today in Endocrinology...keeping you current

Accuracy of Whole Blood Glucose Measurement When Venous Catheter Blood Samples Are Used on Glucose Meters
Diabetes Technology & Therapeutics, 12/16/09

Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/16/09

The relationship between primary health care organization and quality of diabetes care
The European Journal of General Practice, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address